Astroglia Induce Cytotoxic Effects on Brain Tumors via a Nitric Oxide-dependent Pathway Both in Vitro and in Vivo

Neurosurgery

Volumn 54, Issue 5, 2004, Pages 1231-1238

  Samdani, Amer F ^a   Kuchner, Eric B ^a   Rhines, Laurence ^a   Adamson, David C ^a   Lawson, Christopher ^a   Tyler, Betty ^a   Brem, Henry ^a,b   Dawson, Valina L ^a   Dawson, Ted M ^a   Piepmeier, Joseph M ^c   Parsa, Andrew T ^c   Lichtor, Terry ^c   Glick, Roberta P ^c   Westphal, Manfred ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c NONE

Author keywords

Astroglia; Brain tumors; Cytokines; NG Nitro L arginine methyl ester; Nitric oxide

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CELL STIMULATION; CHEMICAL MODIFICATION; CLINICAL PATHWAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DEFENSE MECHANISM; DRUG MECHANISM; FEMALE; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LUNG TUMOR; MACROGLIA; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL LINE;

EID: 2342479791     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000119576.76193.B8     Document Type: Article

References (56)

1. Albina JE, Reichner JS: Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17:39-53, 1998.
2. 2-expressing human carcinoma cells. Nat Med 4:1371-1376, 1998.
3. Baratin M, Ziol M, Romieu R, Kayibanda M, Gouilleux F, Briand P, Leroy P, Haddada H, Renia L, Viguier M, Guillet JG: Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-γ delivery is associated with macrophages recruitment and nitric oxide production. Cancer Gene Ther 8:193-202, 2001.
4. Bhaumik S, Khar A: Induction of nitric oxide production by the peritoneal macrophages after intraperitoneal or subcutaneous transplantation of AK-5 tumor. Nitric Oxide 2:467-474, 1998.
5. Bogdan C: Nitric oxide and the immune response. Nat Immunol 2:907-916, 2001.
6. 2) expression correlates with lymph node status in oral squamous cell carcinoma. J Oral Pathol Med 30:129-134, 2001.
7. Brune B, von Knethen A, Sandau KB: Nitric oxide and its role in apoptosis. Eur J Pharmacol 351:261-272, 1998.
8. Cahlin C, Gelin J, Delbro D, Lonnroth C, Doi C, Lundholm K: Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res 60:1742-1749, 2000.
9. Cao G, Su J, Lu W, Zhang F, Zhao G, Marteralli D, Dong Z: Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Ther 8:497-505, 2001.
10. Carretero J, Obrador E, Esteve JM, Ortega A, Pellicer JA, Sempere FV, Estrela JM: Tumoricidal activity of endothelial cells: Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J Biol Chem 276:25775-25782, 2001.
11. Chang CI, Liao JC, Kuo L: Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61: 1100-1106, 2001.
12. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995.
13. Dawson VL, Kizushi VM, Huang PL, Snyder SH, Dawson TM: Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16:2479-2487, 1996.
14. Eue I: Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism. Int J Cancer 92:426-433, 2001.
15. Ewend MG, Williams JA, Tabassi K, Tyler BM, Babel KM, Anderson RC, Pinn ML, Brat DJ, Brem H: Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Cancer Res 56:5217-5223, 1996.
16. Fricker SP, Slade E, Powell NA: Macrophage-derived superoxide is not required for nitric oxide mediated tumour cell killing by RAW 264 cells. Anticancer Res 19:553-556, 1999.
17. 2-dependent activation of nuclear factor κB: Role in sensitization of human tumor cells to tumor necrosis factor-α-induced cytotoxicity. J Biol Chem 276:8918-8923, 2001.
18. Gath I, Steppuhn A, Maelicke A, Reinhardt S, Forstermann U. Analysis of NO synthase expression in neuronal, astroglial and fibroblast-like derivatives differentiating from PCCT-Mz1 embryonic carcinoma cells. Eur J Cell Biol 78:134-142, 1999.
19. Jadeski LC, Lala PK: Nitric oxide synthase inhibition by N(G)nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 155:1381-1390, 1999.
20. Jadus MR, Williams CC, Avina MD, Ly M, Kim S, Liu Y, Narasaki R, Lowell CA, Wepsic HT: Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway. J Immunol 160:361-368, 1998.
21. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 92:4392-4396, 1995.
22. Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG: Nitric oxide synthase II gene disruption: Implications for tumor growth and vascular endothelial growth factor production. Cancer Res 61:3182-3187, 2001.
23. Kurimoto M, Endo S, Hirashima Y, Hamada H, Ogiichi T, Takaku A: Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J Neurooncol 42:35-44, 1999.
24. Lala PK, Orucevic A: Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev 17:91-106, 1998.
25. Li LM, Kilbourn RG, Adams J, Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51:2531-2535, 1991.
26. Lind DS, Kontaridis MI, Edwards PD, Josephs MD, Moldawer LL, Copeland EM III: Nitric oxide contributes to adriamycin's antitumor effect. J Surg Res 69:283-287, 1997.
27. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
28. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997.
29. Mateo RB, Reichner JS, Albina JE: NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line. J Leukoc Biol 60:245-252, 1996.
30. Mullins DW, Burger CJ, Elgert KD: Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162: 6811-6818, 1999.
31. Murata J, Ricciardi-Castagnoli P, Dessous L'Eglise Mange P, Martin F, Juillerat-Jeanneret L: Microglial cells induce cytotoxic effects toward colon carcinoma cells: Measurement of tumor cytotoxicity with a γ-glutamyl transpeptidase assay. Int J Cancer 70:169-174, 1997.
32. Naama HA, McCarter MD, Mack VE, Evoy DA, Hill AD, Shou J, Daly JM: Suppression of macrophage nitric oxide production by melanoma: Mediation by a melanoma-derived product. Melanoma Res 11:229-238, 2001.
33. Nishikawa M, Sato EF, Kuroki T, Utsumi K, Inoue M: Macrophage-derived nitric oxide induces apoptosis of rat hepatoma cells in vivo. Hepatology 28:1474-1480, 1998.
34. Radomski MW, Jenkins DC, Holmes L, Moncada S: Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51:6073-6078, 1991.
35. Shi Q, Huang S, Jiang W, Kutach LS, Ananthaswamy HN, Xie K: Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53. Cancer Res 59:2072-2075, 1999.
36. Sotomayor EM, DiNapoli MR, Calderon C, Colsky A, Fu YX, Lopez DM: Decreased macrophage-mediated cytotoxicity in mammary-tumor-bearing mice is related to alteration of nitric-oxide production and/or release. Int J Cancer 60:660-667, 1995.
37. Sun H, Gutierrez P, Jackson MJ, Kundu N, Fulton AM: Essential role of nitric oxide and interferon-γ for tumor immunotherapy with interleukin-10. J Immunother 23:208-214, 2000.
38. Sveinbjornsson B, Olsen R, Seternes OM, Seljelid R: Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem Biophys Res Commun 223:643-649, 1996.
39. Tamir S, Tannenbaum SR: The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta 1288:F31-F36, 1996.
40. Thomas C, Nijenhuis AM, Dontje B, Daemen T, Scherphof GL: Tumoricidal response of liver macrophages isolated from rats bearing liver metastases of colon adenocarcinoma. J Leukoc Biol 57:617-623, 1995.
41. Thompson RC, Pardoll DM, Jaffee EM, Ewend MG, Thomas MC, Tyler BM, Brem H: Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors. J Immunother Emphasis Tumor Immunol 19:405-413, 1996.
42. Thomsen LL, Miles DW: Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev 17:107-118, 1998.
43. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41-44, 1995.
44. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ: Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor. Cancer Res 57: 3300-3304, 1997.
45. Timoshenko AV, Lan Y, Gabius HJ, Lala PK: Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination: Effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer 37:1910-1920, 2001.
46. Tonetti M, Millo E, Sturla L, Bisso A, De Flora A: Effects of the murine L929 and L1210 cell lines on nitric oxide and TNF-α production by RAW 264.7 murine macrophages. Biochem Biophys Res Commun 230:636-640, 1997.
47. Verovski VN, Van den Berge DL, Soete GA, Bols BL, Storme GA: Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br J Cancer 74:1734-1742, 1996.
48. Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H: Intratumoral chemotherapy. Neurosurgery 37:1128-1145, 1995.
49. Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K: Intact nitric oxide synthase II gene is required for interferon-β-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res 61:71-75, 2001.
50. Wink DA, Vodovotz Y, Cook JA, Krishna MC, Kim S, Coffin D, DeGraff W, Deluca AM, Liebmann J, Mitchell JB: The role of nitric oxide chemistry in cancer treatment. Biochemistry (Mosc) 63:802-809, 1998.
51. Wood PL, Choksi S, Bocchini V: Inducible microglial nitric oxide synthase: A large membrane pool. Neuroreport 5:977-980, 1994.
52. Xie K, Fidler IJ: Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 17:55-75, 1998.
53. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181:1333-1343, 1995.
54. Yim CY, Bastian NR, Smith JC, Hibbs JB Jr, Samlowski WE: Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res 53:5507-5511, 1993.
55. Yun HY, Dawson VL, Dawson TM: Nitric oxide in health and disease of the nervous system. Mol Psychiatry 2:300-310, 1997.
56. Zielasek J, Hartung HP: Molecular mechanisms of microglial activation. Adv Neuroimmunol 6:191-222, 1996.